BUY IPCA Laboratories Limited — IDBI Capital
IPCA Laboratories share price target & all analyst calls
byIDBI CapitalHorizon: NA (inferred 1–3 months)10 Jul 2026via IDBI Capital Research Calls Telegram
Entry₹1,792Stated
Stop loss₹1,720-4.02% risk
Exit₹1,7203 Aug 2026, 12:08 pm
Stop-loss hit-4.02%
Follow IDBI Capital for new calls(32% target hit, 190 closed calls)Get alertsWatch IPCALAB for new buy/sell callsGet alertsSee 3 active Short-term calls on IPCALABSee 39 active Short-term picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 supporting0 opposing
Supports the BUY call (4)
Neutral / worth noting (0)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
More from IDBI Capital
- BUY CG Power and Industrial Solutions23 Oct 2026 · ~2 weeks · target ₹830 · SL hit
- BUY Apollo Hospitals Enterprise23 Oct 2026 · ~2 weeks · target ₹8,018 · Active
- BUY Eternal23 Oct 2026 · ~2 weeks · target ₹322 · Active
- BUY Bata India22 Oct 2026 · ~2 weeks · target ₹680 · SL hit
- BUY Tanla Platforms22 Oct 2026 · ~3 months · target ₹640 · SL hit